[1]
|
E. A. Johnson, S. I. Svetlov, K. K. Wang, et al., “Cell-Specific DNA Fragmentation May Be Attenuated by a Survivin-Dependentmechanism after Traumatic Brain Injury in Rats,” Experimental Brain Research, Vol. 167, No. 1, 2005, pp. 17-26. doi:10.1007/s00221-005-2362-2
|
[2]
|
I. Yatsiv, N. Grigoriadis, C. Simeonidou, et al., “Erythropoietinis Neuroprotective, Improves Functional Recovery, and Reducesneuronal Apoptosis and Inflammation in a Rodent Modelof Experimental Closed Head Injury,” FASEB Journal, Vol. 19, No. 12, 2005, pp. 1701-1703.
|
[3]
|
J. Y. Jiang and C. Z. Luo, “Modern Brain Injury,” The Second Military Medical University, Shanghai, 2004, pp. 417-419.
|
[4]
|
P. Lei, L. Z. Tian, Y. Wang, et al., “General Treatment for Severe Brain Injury,” Chinese Journal of Trauma, Vol. 21, No. 7, 2005, pp. 541-543.
|
[5]
|
P. Lei, “Master the Key Points in Treatment of Severe Traumatic Brain Injury,” Magazine Trauma Surgery, Vol. 8, No. 5, 2006, pp. 385-387.
|
[6]
|
P. G. Marciano, J. Brettschneider, E. Manduchi, et al., “Neuron-Specific mRNA Complexity Responses during Hippo-Campal Apoptosis after Traumatic Brain Injury,” Journal of Neuroscience, Vol. 24, No. 12, 2004, pp. 2866-2876.
doi:10.1523/JNEUROSCI.5051-03.2004
|
[7]
|
M. Hasselblatt, H. Ehrenreich and A. L. Siren, “The Brain Erythropoietinsystem and Its Potential for Therapeutic Exploitationin Brain Disease,” Journal of Neurosurgical Anesthesiology, Vol. 18, No. 2, 2006, pp. 132-138.
doi:10.1097/00008506-200604000-00007
|
[8]
|
H.-T. Lan and Q. J. Zhang, “Recombinant Human Erythropoietin on Focal Cerebral Ischemia-Reperfusion Injury Inflammation of the Protective Effect of r-HuEPO on inflamematory injury induced by focal cerebral ischamia/reperfusion in rats,” Chinese Neurosurgery, Vol. 22, No. 1, 2006, pp. 51-54.
|
[9]
|
A. Kumral, S. Genc, E. Ozer, et al., “Erythropoietin Downregulatesbax and DP5 proapoptotic Gene Expression In Neonatalhypoxic-Ischemic Brain Injury,” Biology of the Neonate, Vol. 89, No. 3, 2006, pp. 205-210.
doi:10.1159/000089951
|
[10]
|
W. J. van Houdt, Y. S. Haviv, B. Lu, et al., “The Human Survivinpromoter: A Novel Transcriptional Targeting Strategy Fortreatment of Glioma,” Journal of Neurosurgery, Vol. 104, No. 4, 2006, pp. 583-592.
doi:10.3171/jns.2006.104.4.583
|
[11]
|
P. Sompol, Y. Xu, W. Ittarat, et al., “NF-κB-Associated Mn-SOD Induction Protects against β-Amyloid-Induced Neuronal Apoptosis,” Journal of Molecular Neuroscience, Vol. 29, No. 3, 2006, pp. 279-288.
doi:10.1385/JMN:29:3:279
|
[12]
|
A. J. Williams, J. R. Dave and F. C. Tortella, “Neuroprotection with the Proteasome Inhibitor MLN519 in Focal Ischemic Brain Injury: Relation to Nuclear Factor κB (NF-κB), Inflammatory Gene Expression, and Leukocyte Infiltration,” Neurochemistry International, Vol. 49, No. 2, 2006, pp. 106-112. doi:10.1016/j.neuint.2006.03.018
|
[13]
|
National Kidney Foundation—Dialysis Outcomes Quality Initiative, “NKF-DOQI Clinical Practice Guidelines for the Treatment of Anemia of Chronic Renal Failure,” American Journal of Kidney Diseases, Vol. 30, Suppl. 3, 1997, pp. S192-S240.
|
[14]
|
A.-L. Siren, et al., “Erythropoietin Prevents Neuronal Apoptosis after Cerebral Ischemia and Metabolic Stress,” Proceedings of the National Academy of Sciences, Vol. 98, No. 7, 2001, pp. 4044-4049. doi:10.1073/pnas.051606598
|
[15]
|
P. Lei, et al., “Protective Role of Erythropoietin for Traumatic Brain Injury with Shock in Rats,” Chinese Journal of Neurosurgery, Vol. 24, No. 7, 2008, pp. 553-555.
|